First CRISPR treatment for blood diseases shows early benefits in two patients
The first two patients to receive a CRISPR-based treatment for the inherited blood disorders sickle…
Category: Boston
STAT Plus: Novo Nordisk’s parent company to launch research incubator in Boston
Novo Holdings, the investment firm behind pharmaceutical giant Novo Nordisk, is committing $25 million over…